US90240B1061
US90240B1061
Tyra Biosciences, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.37B EUR | 1.91B EUR | 2.28B EUR | 1.41B EUR |
Enterprise Value | 843.39M EUR | 1.84B EUR | 2.2B EUR | 1.34B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -7.2x | -- | -- | -- |
Price to Sales | -- | -- | -- | -- |
Price to Book | 3.36x | 5.39x | 5.88x | 5.45x |
EV/Revenue | -- | -- | -- | -- |
EV/EBITDA | -5.27x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -4.6% | -5.77% | -4.5% | -4.94% |